scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Core Viewpoint - scPharmaceuticals Inc. is focused on revolutionizing cardiorenal healthcare through patient-centric innovations and will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 [1]. Company Overview - scPharmaceuticals is dedicated to advancing cardiorenal care with innovative, integrated treatments that address unmet patient needs [3]. - The company aims to be a leading advocate for patient-centric cardiorenal care, promoting global health improvements through specialized, multidisciplinary approaches [4]. - scPharmaceuticals is headquartered in Burlington, MA, and is expanding its reach with integrated therapies and products to improve patient lives [4].